1. Home
  2. IGC vs JYD Comparison

IGC vs JYD Comparison

Compare IGC & JYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • JYD
  • Stock Information
  • Founded
  • IGC 2005
  • JYD 2001
  • Country
  • IGC United States
  • JYD China
  • Employees
  • IGC N/A
  • JYD N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • JYD Oil Refining/Marketing
  • Sector
  • IGC Health Care
  • JYD Consumer Discretionary
  • Exchange
  • IGC Nasdaq
  • JYD Nasdaq
  • Market Cap
  • IGC 20.2M
  • JYD 23.3M
  • IPO Year
  • IGC N/A
  • JYD 2023
  • Fundamental
  • Price
  • IGC $0.31
  • JYD $0.18
  • Analyst Decision
  • IGC Strong Buy
  • JYD
  • Analyst Count
  • IGC 2
  • JYD 0
  • Target Price
  • IGC $3.88
  • JYD N/A
  • AVG Volume (30 Days)
  • IGC 230.9K
  • JYD 2.3M
  • Earning Date
  • IGC 08-07-2025
  • JYD 07-01-2025
  • Dividend Yield
  • IGC N/A
  • JYD N/A
  • EPS Growth
  • IGC N/A
  • JYD N/A
  • EPS
  • IGC N/A
  • JYD N/A
  • Revenue
  • IGC $1,236,000.00
  • JYD $77,444,271.00
  • Revenue This Year
  • IGC N/A
  • JYD N/A
  • Revenue Next Year
  • IGC $16.45
  • JYD N/A
  • P/E Ratio
  • IGC N/A
  • JYD N/A
  • Revenue Growth
  • IGC 1.65
  • JYD 13.54
  • 52 Week Low
  • IGC $0.25
  • JYD $0.09
  • 52 Week High
  • IGC $0.55
  • JYD $8.00
  • Technical
  • Relative Strength Index (RSI)
  • IGC 49.31
  • JYD 32.88
  • Support Level
  • IGC $0.30
  • JYD $0.19
  • Resistance Level
  • IGC $0.32
  • JYD $0.21
  • Average True Range (ATR)
  • IGC 0.02
  • JYD 0.01
  • MACD
  • IGC -0.00
  • JYD 0.03
  • Stochastic Oscillator
  • IGC 20.00
  • JYD 0.00

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

About JYD Jayud Global Logistics Limited

Jayud Global Logistics Ltd is a end-to-end supply chain solution providers in China, with a focus on providing cross-border logistics services. It offers freight forwarding services, (ii) supply chain management, and (iii) other value-added services.

Share on Social Networks: